Symposium 5: Lecanemab Three Years Post-Approval: A Comprehensive Multicenter, Real-World, Retrospective Study (LEADER) in Diverse US Clinical Settings

About this session

Presentations: (1) Real-World Lecanemab Utilization and Outcomes from Initiation Through Maintenance Therapy in Early Alzheimer's Disease; (2) Sex-Based Outcomes of Lecanemab in Early Alzheimer's Disease; (3) At-Home Subcutaneous Lecanemab Administration. All from the LEADER multicenter, real-world, retrospective study.

Speakers

• MS

  Marwan Sabbagh

  Barrow Neurological Institute

  Chair

• JS

  Jose Soria

  The Neuron Clinic

  Speaker

• TC

  Tinatin Chabrashvili

  SUNY Upstate Medical University

  Speaker

• BB

  Brent Berry

  Minneapolis Clinic of Neurology

  Speaker